SPOTLIGHT: TomoTherapy launches IPO

TomoTherapy is launching an IPO designed to raise $185 million. TomoTherapy developed, manufactures and sells the Hi Art system, a radiation therapy system for the treatment of a wide variety of cancers. Release

Suggested Articles

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.

The role gives one of the driving forces behind Bristol Myers Squibb’s $74 billion takeover of Celgene the chance to help build biotechs.

The appointment gives Sino-American biotech Brii the experience of a man who helped Gilead launch eight drugs in China in quick succession.